Free Trial
→ $100 Trillion “AI Metal” Found in American Ghost Town (From Brownstone Research) (Ad)tc pixel Free UTHR Stock Alerts

United Therapeutics (UTHR) SEC Filings & 10K Form

United Therapeutics logo
$401.04 -3.99 (-0.98%)
As of 02:54 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent United Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/12/2025
1:14 PM		ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2025
6:41 PM		ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2025
12:32 PM		ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2025
3:50 PM		ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2025
3:30 PM		Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025
3:31 PM		ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025
3:31 PM		MALCOLM JAN (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025
3:31 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2025
3:10 PM		Thompson Tommy G (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2025
3:25 PM		ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2025
3:13 PM		MALCOLM JAN (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2025
6:53 AM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025
3:39 PM		CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025
3:07 PM		CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/02/2025
6:00 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2025
3:32 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2025
3:05 PM		MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2025
3:42 PM		MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2025
4:17 PM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
5:40 AM		United Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/30/2025
5:36 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2025
5:34 AM		United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2025
5:56 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2025
3:32 PM		MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/14/2025
3:30 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2025
3:22 PM		MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/27/2025
3:39 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:30 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025
4:36 PM		MAHON PAUL A (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2025
3:36 PM		Giltner Richard (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:38 PM		Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
4:25 PM		Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
3:57 PM		Giltner Richard (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2025
7:48 AM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:30 PM		EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:39 PM		EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2025
3:30 PM		Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
9:44 AM		United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
05/02/2025
3:31 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
5:32 AM		United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2025
5:33 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
5:31 AM		United Therapeutics (Filer)
Form DEF 14A
04/29/2025
5:33 AM		United Therapeutics (Filer)
Form DEFA14A
04/29/2025
5:36 AM		United Therapeutics (Filer)
Form ARS
04/28/2025
5:31 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
3:30 PM		DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
3:28 PM		DWEK RAYMOND (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
3:02 PM		DWEK RAYMOND (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/07/2025
3:01 PM		DWEK RAYMOND (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/07/2025
8:05 AM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
3:31 PM		Thompson Tommy G (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:47 PM		Thompson Tommy G (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
5:11 PM		PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:11 PM		PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2025
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
3:31 PM		ROTHBLATT MARTINE A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:33 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:41 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM		KURZWEIL RAY (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:34 PM		Thompson Tommy G (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
5:33 AM		United Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
5:35 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:30 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
3:32 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
9:25 AM		United Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/05/2025
6:10 AM		STATE STREET CORP (Filed by)
United Therapeutics (Subject)
Form SCHEDULE 13G
01/22/2025
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:31 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
3:30 PM		PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:57 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
3:29 PM		PATUSKY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:31 PM		Mesa Nilda (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:32 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:08 PM		Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2024
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:31 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
4:51 PM		SULLIVAN LOUIS W (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/17/2024
3:31 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:38 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:32 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
3:30 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
5:44 AM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:37 PM		MAHON PAUL A (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:04 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:32 AM		Olian Judy D. (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:17 PM		Mesa Nilda (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
4:07 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
3:30 PM		EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:33 PM		Giltner Richard (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:45 PM		CAUSEY CHRISTOPHER (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:23 PM		BENKOWITZ MICHAEL (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2024
5:32 AM		United Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
5:34 AM		United Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
3:30 PM		EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:13 PM		EDGEMOND JAMES (Reporting)
United Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:30 PM		EDGEMOND JAMES (Reporting)
United Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:UTHR) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel
GENIUS Act: The Plot to Seize Your Cash?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel